Abstract:Aim: To observe the changes of serum interleukin-8, monocyte chemoattractant protein-1and interleukin-10 in patients with obstructive sleep apnea hypopnea syndrome (OSAHS), and to explore the significance. Methods: Thirty-five patients with obstructive sleep apnea hypopnea syndrome confirmed by polysomnography, who hospitalized in Department of Respiratory Medicine, First Hospital of Lanzhou University from December 2002 to December 2003, were selected. Ten with moderate and severe OSAHS of these patients had been treated by nasal continuous positive air pressure for over half a year, were selected as treatment group aged (51 ±13) years old. The included patients all knew the fact of the treatment program and agreed. Twenty-five healthy subjects in this hospital were recruited as the control group during the same period, and agreed to take part in the experiment. The apnea hypopnea index and lowest blood oxygen saturation were detected by the Polywin polysomnography. The serum levels of interleukin-8, interleukin-10 and monocyte chemoattractant protein-1 were measured by enzyme linked immune sandwich assay. The patients with moderate and severe OSAHS were treated with continuous positive airway. The pressure of nasal continuous positive airway was 0.588-1.176 kPa for 6-8 hours every day. The t-test was performed among the comparison of groups, and the paired t-test was conducted among the comparison within the groups. The correlation check among indexes was done by linear correlation analysis. Results: Before treatment the number of people kept the upper number, and after treatment 10 patients with moderate and severe OSAHS and 25 healthy people were involved in the result analysis. 1 The serum interleukin-8 and monocyte chemoattractant protein-1 levels in patients with OSAHS (35 cases) were significantly higher than those in the control group (t=5.498, 9.626, P < 0.01), and the level of serum interleukin-10 was lower obviously than that in the control group (t=-4.667,P < 0.01). 2 The levels of serum interleukin-8 and monocyte chemoattractant protein-1 in patients with OSAHS had significantly positive correlation with apnea hypopnea index (r=0.671, 0.742, P < 0.01), and had negative correlation with lowest blood oxygen saturation (r=-0.442, -0.531, P < -0.01).The level of serum interleukin-10 had significantly negative correlation with apnea hypopnea index (r=-0.688, P < 0.01), and had positive correlation with lowest blood oxygen saturation (r=0.454, P < 0.01).3 The serum interleukin-10 and interleukin-8 had remarkably negative correlation with monocyte chemoatractant protein-1 (r=0.509, -0.666, P < 0.01), and the interleukin-8 had obviously positive correlation with monocyte chemoattractant protein-1 (r=0.706,P < 0.01). 4 The levels of serum in-terleukin-8 and monocyte chemoattractant protein-1 in patients of treat-ment group (10 cases)after half year treatment were lower significantly than those before treatment (t=4.896, 5.609, P < 0.01).The level of in-terleukin-10 was significantly higher than that before treatment (t=-4.625, P < 0.01). Conclusion: 1 The hypoxia induces the increase of serum interleukin-8 and monocyte chemoattractant protein-1, and the decrease of interleukin-10 in patients with OSAHS, which may join the occurrence of cardiovascular disease. 2 The nasal continuous positive airway treatment may reach the effect of preventing the occurrence of cardiovascular lesion in patients with OSAHS by means of relieving ischemia, decreasing the production of interleukin-8 and monocyte chemoattractant protein-1 and increasing the production of interleukin-10.

Change and significance of 8-isoprostane in exhaled breath condensate in obstructive sleep apnea-hypopnea syndrome

Clinic significances of 8-isoprostane in Exhaled Breath Condensate in COPD

Correlation of serum 8-hydroxydeoxyguanylate level with disease severity and oxidative stress in osahs patients

Clinical Study on Oxidation and Antioxidation in Patients with Obstructive Sleep Apnea Hypopnea Syndrome

Changes and significances of serum interleukin-8 and monocyte chemoattractant protein-1 levels in patients with obstructive sleep apnea syndrome

Changes of serum interleukin-8 and monocyte chemoattractant protein-1 levels in patients with obstructive sleep apnea hypopnea syndrome

A Community Study of the Risk for Obstructive Sleep Apnea and Respiratory Inflammation in an Adult Chinese Population.

Study about the change of lipid metabolism in patients of obstructive sleep apneahypopnea syndrome

Clinical Significance of 8-Lsoprostaglandin in Exhaled Breath Condensate of Patients with Acute Lung Injury

The impact of obstructive sleep apnea hypopnea syndrome on the changes of peripheral blood lymphocyte immunophenotype and C-reactive protein

Circulating markers of oxidative stress and risk of incident cardiovascular events in obstructive sleep apnea

Clinical significance of nitric oxide and 8-isoprostane in exhaled breath condensate in chronic obstructive pulmonary disease

Hydrogen Peroxide is Increased after Sleep in Exhaled Breath Condensate of Patients with Obstructive Sleep Apnea-Hypopnea Syndrome

Research advances of measurements of inflammatory factors in exhaled breath condensate of obstructive sleep apnea syndrome

[Significance of Apnea Hypopnea Time Index in Obstructive Sleep Apnea Hypopnea Syndrome Patients and Possible Correlation Between Polysomnographic Parameters and Severity of the Disease].

Exhaled breath condensate levels of 8-isoprostane, growth related oncogene alpha and monocyte chemoattractant protein-1 in patients with chronic obstructive pulmonary disease

Changes of Serum Adiponectin Level in Patients with Obstructive Sleep Apnea Hypopnea Syndrome and Its Relationship with Sleep Monitoring Indexes

Research on the Association Between Obstructive Sleep Apnea Hypopnea Syndrome Complicated With Coronary Heart Disease and Inflammatory Factors, Glycolipid Metabolism, Obesity, and Insulin Resistance

[The influence of chronic intermittent hypoxia on insulin function in OSAHS patients]

[Relationship Between Serum Homocysteine Level and Oxidative Stress in Patients with Obstructive Sleep Apnea-Hypopnea Syndrome].

Changes in Plasma Interleukin-18 and Monocyte Chemotaxis Protein-1 in Obstructive Sleep Apnea Syndrome and Their Significance